About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | COPD Clinical Trials in Houston | 162 Studies

Clinical Trials COPDHouston

COPD Clinical Trials in Houston

Find 162 clinical trials for copd near Houston, Texas. Connect with research centers in your area.

All COPD trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 162 trials

CompletedCo-administration of Olodaterol Respimat® and Tiotropium Handihaler®The overall objective of this study is to assess efficacy and safety of 12 weeks, once daily, orally inhaled co-administration of olodaterol 5 µg (delivered by the Respimat®…NCT01696058·Anniston, Alabama and 93 others

Page 1 of 9Next

COPD Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedA 24-week Evaluation of GSK573719/Vilanterol (62.5/25mcg) and Components in COPDThis is a phase III multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of GSK573719/GW642444 Inhalation Powder…NCT01313650·Tucson, Arizona and 164 others

TerminatedLung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) StudyMulticenter, randomized, assessor-blinded controlled study of safety and effectiveness of the PneumRx, Inc. RePneu Lung Volume Reduction Coil (RePneu LVRC) SystemNCT01608490·Birmingham, Alabama and 28 others

CompletedValidation of a New Shortness of Breath With Daily Activities Questionnaire in Patients With Chronic Obstructive Pulmonary DiseaseThe purpose of this study is to evaluate a new questionnaire to capture the patient experience of COPD.NCT00984659·Jasper, Alabama and 38 others

RecruitingSTRIVE Post-Market Registry StudyThis is a single-arm, prospective, multi-center, Registry study to evaluate the long-term safety and effectiveness of the Spiration Valve System (SVS) for the treatment of severe…NCT04302272·Phoenix, Arizona and 15 others

CompletedStudy in Patients With COPDThe purpose of this study is to determine the efficacy and safety of the investigational drug in the treatment of COPD in comparison with a placebo.NCT00215449·Bessemer, Alabama and 67 others

CompletedAn Observational Study to Assess RSV-associated Illness in Adults With COPD and/or CHFThe primary objective of this observational study is to determine the incidence of medically attended (inpatient or outpatient) acute respiratory illnesses or events leading to…NCT01455402·Birmingham, Alabama and 59 others

CompletedEvaluation of the Spiration® Valve System for Emphysema to Improve Lung FunctionEMPROVE is a multicenter, prospective, randomized, controlled study designed to evaluate the safety and long-term effectiveness of the Spiration Valve System in patients with…NCT01812447·Fort Smith, Arkansas and 33 others

CompletedComparing the Efficacy of Tiotropium + Olodaterol (5/5 µg) Fixed Dose Combination (FDC) Over Tiotropium 5µg in Reducing Moderate to Severe Exacerbations in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease.The overall objective is to assess the effect of once daily tiotropium + olodaterol fixed dose combination compared to 5 µg tiotropium (both delivered with the Respimat® inhaler)…NCT02296138·Andalusia, Alabama and 817 others

RecruitingeValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 InflammationDepemokimab is being developed as a treatment for individuals with moderate to severe Chronic Obstructive Pulmonary Disorder (COPD).NCT07177339·Newport Beach, California and 120 others

CompletedCharacterisation of 24-hour FEV1-time Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary DiseaseThe study is intended to characterize the lung function profile of BI1744 in COPD patients where patients will perform pulmonary function tests at regular intervals for 24 hours…NCT00932646·Jasper, Alabama and 12 others

TerminatedBronchitis and Emphysema Advice and Training to Reduce HospitalizationEXECUTIVE SUMMARY: Purpose: To evaluate the efficacy and cost-effectiveness of a novel intervention incorporating self-management education, an action plan, and case-management…NCT00395083·Phoenix, Arizona and 21 others

TerminatedA Study to Evaluate Biomarkers in Chronic Obstructive Pulmonary DiseaseThe primary objective of this study is to identify biomarkers that can be used for evaluation of efficacy in subjects presenting with AECOPDNCT01268072·Baltimore, Maryland and 9 others

CompletedEfficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD); (PINNACLE 1)The overall objective of this study is to assess the efficacy and safety of treatment with PT003 (GFF MDI), PT005 (FF MDI), PT001 (GP MDI), and open-label tiotropium bromide…NCT01854645·Andalusia, Alabama and 138 others

TerminatedA Study Designed to Evaluate ODSH in Subjects With Exacerbations of COPDThe purpose of this study is to determine whether ODSH, when added to conventional treatment, is more effective in treating COPD exacerbations than conventional therapy alone.NCT00457951·Orange, California and 37 others

CompletedSmoking Cessation in Subjects With Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD).This study is to be conducted in subjects with mild-to-moderate COPD who are cigarette smokers with the intent of demonstrating differences in smoking cessation between…NCT00285012·Birmingham, Alabama and 31 others

TerminatedA Pilot Study of Danirixin for Disease Progression in Chronic Obstructive Pulmonary Disease (COPD)This is a pilot study to investigate the effect of danirixin hydrobromide 35 milligram (mg) tablets on lung function and health related quality of life (HRQoL) in subjects with…NCT03170232·Birmingham, Alabama and 10 others

CompletedA Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Period in Subjects With Moderate to Very Severe COPD (Sophos)This is a Phase III randomized, double-blind, parallel group, multi-center, 52-week COPD exacerbation and lung function study with PT009 320/9.6 μg, PT009 160/9.6 μg and PT005 9.6…NCT02727660·Dothan, Alabama and 281 others

CompletedDose Finding Study in COPDThe primary objective of this study is to determine the optimum dose of BEA 2180 BR inhalation solut ion delivered by the Respimat ? inhaler once daily for four weeks in patients…NCT00122434·Birmingham, Alabama and 42 others

CompletedA Study Comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF 5993 With the Fixed Dose Dual Combination CHF 1535 in Subjects With COPDThe purpose of this study is to compare CHF 5993 with CHF 1535 in improving lung function, reducing moderate and severe COPD exacerbations, and other clinical efficacy and safety…NCT04320342·Birmingham, Alabama and 435 others

Other Conditions in Houston

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia